Literature DB >> 29881908

Assessment of polypharmacy in elderly patients by using data from dispensed medications in community pharmacies: analysis of results by using different methods of estimation.

Luciana Carla Chiapella1, Jorgelina Montemarani Menna2, María Eugenia Mamprin3.   

Abstract

Background Estimating the prevalence of polypharmacy is essential for the evaluation of public health. Many different methodologies are used to determine the number of drugs used by a patient. Objective To analyse and compare three different methods (simultaneous, cumulative and continuous medication) to determine the number of drugs used by a patient, to estimate the prevalence of polypharmacy and to evaluate the possible association between polypharmacy and the gender and age of patients. Method Cross-sectional observational study carried out between April and September 2015. Data were acquired from prescriptions corresponding to 3972 patients aged 65 years old or older in ten community pharmacies in Argentina. Results The prevalence of polypharmacy varied significantly according to the method used. Major polypharmacy (use of five or more drugs) was detected in 20.5-47.1% of the patients. The association between gender, age and polypharmacy was statistically significant only when using the continuous medication method. The prevalence of minor polypharmacy (use of two to four drugs) was similar with the three methods. Conclusion These results contribute to deciding which is the best method to determine polypharmacy according to the objective of future studies and considering the advantages and disadvantages of each of them.

Entities:  

Keywords:  Community pharmacy; Drug utilization; Elderly; Methodology; Polypharmacy; Potentially inappropriate medication

Mesh:

Year:  2018        PMID: 29881908     DOI: 10.1007/s11096-018-0663-3

Source DB:  PubMed          Journal:  Int J Clin Pharm


  6 in total

1.  Methods for estimating the occurrence of polypharmacy by means of a prescription database.

Authors:  L Bjerrum; J U Rosholm; J Hallas; J Kragstrup
Journal:  Eur J Clin Pharmacol       Date:  1997       Impact factor: 2.953

2.  [Use of medication in elderly people don't institutionalized].

Authors:  Martín Regueiro; Nicolás Mendy; Martín Cañás; Hugo Osvaldo Farina; Pablo Nagel
Journal:  Rev Peru Med Exp Salud Publica       Date:  2011-12

3.  Gender and polypharmacotherapy in the elderly: a clinical challenge.

Authors:  Christina Hofer-Dückelmann
Journal:  Handb Exp Pharmacol       Date:  2012

4.  Polypharmacy: correlations with sex, age and drug regimen. A prescription database study.

Authors:  L Bjerrum; J Søgaard; J Hallas; J Kragstrup
Journal:  Eur J Clin Pharmacol       Date:  1998-05       Impact factor: 2.953

5.  [Analysis of medication prescription in an Argentinian geriatric hospital].

Authors:  Marta Marzi M; Valeriana Diruscio A; Mariano Núñez H; Miryam Pires S; Nora Quaglia B
Journal:  Rev Med Chil       Date:  2013-02       Impact factor: 0.553

6.  Application of a framework for determining number of drugs.

Authors:  Amber M Goedken; Brian C Lund; Elizabeth A Cook; Mary C Schroeder; John M Brooks
Journal:  BMC Res Notes       Date:  2016-05-13
  6 in total
  3 in total

1.  Association of Hyper-Polypharmacy With Clinical Outcomes in Heart Failure With Preserved Ejection Fraction.

Authors:  Masatoshi Minamisawa; Brian Claggett; Kota Suzuki; Sheila M Hegde; Amil M Shah; Akshay S Desai; Eldrin F Lewis; Sanjiv J Shah; Nancy K Sweitzer; James C Fang; Inder S Anand; Eileen O'Meara; Jean-Lucien Rouleau; Bertram Pitt; Marc A Pfeffer; Scott D Solomon; Orly Vardeny
Journal:  Circ Heart Fail       Date:  2021-10-22       Impact factor: 8.790

2.  Prevalence and factors associated with polypharmacy: a systematic review and Meta-analysis.

Authors:  Mahin Delara; Lauren Murray; Behnaz Jafari; Anees Bahji; Zahra Goodarzi; Julia Kirkham; Mohammad Chowdhury; Dallas P Seitz
Journal:  BMC Geriatr       Date:  2022-07-19       Impact factor: 4.070

3.  Effect of a pharmacist-led educational intervention on clinical outcomes: a randomised controlled study in patients with hypertension, type 2 diabetes and hypercholesterolaemia.

Authors:  Clement Delage; Hélène Lelong; Francoise Brion; Jacques Blacher
Journal:  Eur J Hosp Pharm       Date:  2021-06-28
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.